RxDoctor Payments Data

Seann Willson, MD

Orthopaedic Surgery · Flint, MINPI 1033236823

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $215,850 of the $268,989 with a category attached, or 80.2%. Stryker accounts for 99.8% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $117,441, more than ten times the $167 reported in 2019. Among orthopaedic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$268,989in general payments, 2019–2025

Across 283 payments — averaging $950.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$269K
  • Zimmer Biomet$193
  • Welch Allyn$129
  • Heron Therapeutics, Inc.$64
  • Johnson & Johnson$30
  • Microport Orthopedics Inc$23

What the payments were for

  • Consulting fees$215,85080%
  • Travel & lodging$47,03717%
  • Food & beverage$5,9732%
  • Other$1290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$268,989 in reported general payments places this provider in the 95th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$195,410
Medicare patients
374
Services billed
9,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban24$11,706
Diclofenac Sodium24$2,990
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen200$1,167
Gabapentin217$835
Meloxicam302$763
Mupirocin141$758
Prednisone319$689
Methylprednisolone118$672
Doxycycline Hyclate158$562
Doxycycline Monohydrate41$346
Ibuprofen32$255
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$207
Acetaminophen-CodeineAcetaminophen With Codeine11$56
Amoxicillin15$40

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$30$11,70624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 829 orthopaedic surgery providers in Michigan.

Other orthopaedic surgery in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →